Seelos Therapeutics Inc (SEEL)

[mean gene]

We Are not countless, how do you propose they are going to pay for the trials for Rayva and Fispemifene if they are successful. There may be an opportunity to merge with another company or buy the rights for Vitaros in Canada or the U.S. Who knows maybe a forward stock split. I do not believe anyone who is long this stock would want the company to be in situation like they were before when they sold the rights to the U.S. for a pittance. We will see how Sarissa votes on the share raise. I have been in this stock for several years and not pleased with the current pps, but it is what it is, my average pps is $3.54 and I know it is a gamble and I have taken the risk. I believe the risk/reward in this stock favors the reward. GLTA